We are live on
!
Find out more
GP
Girard Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
17.26%
This Fund
S&P 500
This Quarter
Est. Return
+2.76%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$462M
AUM Growth
+$48M
(+12%)
Cap. Flow
+$37.7M
Cap. Flow
% of AUM
8.17%
Top 10 Holdings %
Top 10 Hldgs %
22.16%
Holding
273
New
44
Increased
150
Reduced
60
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.53M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.4M |
| 3 |
Edison International
EIX
|
+$1.37M |
| 4 |
Merck
MRK
|
+$1.37M |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
+$1.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.09M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$919K |
| 3 |
Coca-Cola
KO
|
+$666K |
| 4 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$515K |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$485K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.49% |
| 2 | Financials | 11.84% |
| 3 | Technology | 10.69% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Staples | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Cincinnati Financial
CINF
$27.9B
| $299K | 0.06% |
4,131
+61
| +1% | +$4.33K |
|
202
Estee Lauder
EL
$30.3B
| $298K | 0.06% |
3,104
-320
| -9% | -$29.4K |
|
|
AET
203
DELISTED
Aetna Inc
AET
| $297K | 0.06% |
+1,953
| New | +$276K |
|
204
Globe Life
GL
$14.3B
| $294K | 0.06% |
3,844
+12
| +0.3% | +$913 |
|
205
Exelon
EXC
$47B
| $293K | 0.06% |
11,379
-867
| -7% | -$22.1K |
|
206
iShares MSCI EAFE ETF
EFA
$75.8B
| $291K | 0.06% |
4,460
-196
| -4% | -$12.7K |
|
207
Microchip Technology
MCHP
$43.7B
| $288K | 0.06% |
7,462
+66
| +0.9% | +$2.6K |
|
208
BP
BP
$108B
| $287K | 0.06% |
9,329
+416
| +5% | +$12.9K |
|
|
GPM
209
DELISTED
Guggenheim Enhanced Equity Income Fund
GPM
| $277K | 0.06% |
+33,500
| New | +$277K |
|
210
Southern Company
SO
$106B
| $276K | 0.06% |
5,764
-402
| -7% | -$20.2K |
|
211
Lumen
LUMN
$6.57B
| $271K | 0.06% |
11,369
+535
| +5% | +$13.4K |
|
212
Phillips 66
PSX
$83.7B
| $271K | 0.06% |
3,275
+23
| +0.7% | +$1.81K |
|
213
Marathon Petroleum
MPC
$92.1B
| $270K | 0.06% |
+5,163
| New | +$267K |
|
|
MFA
214
MFA Financial
MFA
$944M
| $268K | 0.06% |
+8,000
| New | +$265K |
|
215
Regeneron Pharmaceuticals
REGN
$70.5B
| $267K | 0.06% |
+543
| New | +$238K |
|
|
MMP
216
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $266K | 0.06% |
3,731
+85
| +2% | +$6.24K |
|
|
ESRX
217
DELISTED
Express Scripts Holding Company
ESRX
| $266K | 0.06% |
4,169
+756
| +22% | +$47.5K |
|
218
Biogen
BIIB
$29.5B
| $262K | 0.06% |
965
-98
| -9% | -$25.9K |
|
219
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.7B
| $258K | 0.06% |
1,211
+177
| +17% | +$37.1K |
|
|
XLNX
220
DELISTED
Xilinx Inc
XLNX
| $253K | 0.05% |
+3,928
| New | +$248K |
|
221
iShares S&P 500 Growth ETF
IVW
$73.5B
| $252K | 0.05% |
7,372
+688
| +10% | +$23.3K |
|
222
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.95B
| $251K | 0.05% |
+27,368
| New | +$245K |
|
223
Medtronic
MDT
$107B
| $251K | 0.05% |
2,828
-87
| -3% | -$7.34K |
|
224
Vanguard High Dividend Yield ETF
VYM
$79.7B
| $251K | 0.05% |
3,213
+126
| +4% | +$9.81K |
|
225
McCormick & Company Non-Voting
MKC
$14B
| $245K | 0.05% |
5,024
-328
| -6% | -$16.6K |
|
Similar funds
PO
PRIG
KI
H
RVPG
AC
AT
IFAM
Girard Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Girard Partners held 273 positions worth $462M, up 12% from $414M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Girard Partners deployed $37.7M of net new capital in Q2 2017, opening 44 new positions and adding to 150 existing holdings. Its largest new stake was Edison International: 17,087 shares worth $1.34M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $1.09M trimmed.
- Girard Partners's largest Q2 2017 buy was Edison International: 17,087 shares worth $1.34M.
- Girard Partners added most to JPMorgan Chase in Q2 2017, an estimated $1.53M increase.
- Girard Partners's biggest Q2 2017 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.09M.
- Girard Partners fully exited Vanguard Short-Term Bond ETF in Q2 2017, selling an estimated $485K.
- Girard Partners's ten largest holdings make up 22% of its $462M portfolio in Q2 2017.
- Girard Partners opened 44 new positions and closed 8 in Q2 2017.
- Girard Partners's portfolio value rose 12% quarter-over-quarter to $462M.
Based on Girard Partners's 13F filing for Q2 2017, filed 8 Aug 2017.